http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007146543-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate | 2006-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007146543-A |
| titleOfInvention | PIPERAZINE-PIPERIDINE ANTAGONISTS AND 5HT1A RECEPTOR AGONISTS |
| abstract | 1. The compound of formula (I ')! ! and pharmaceutically acceptable salts and hydrates of said compound,! where each of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15 and R16 is independently -H, (C1-C6) -alkyl, (C1 -C6) -haloalkyl, (C2-C6) -alkenyl, or (C2-C6) -alkynyl, halogen, - CF3, -NO2, -CN, -OR25, -OSO2R25, -SR25, -SO2R25, -SO2N (R25 ) 2, -N (R25) 2, -C (O), -COR25, -CO2R25, -NR25CO2R25, -NR25COR25, -NR25CON (R25) 2, or -CON (R25) 2; ! each of Ra and Rb is independently —H or —CH3; ! R25 is —H, either linear or branched (C1-C6) alkyl, (C1-C6) haloalkyl, (C2-C6) alkenyl, or (C2-C6) alkynyl; and! n represents 0, 1 or 2.! 2. A compound or pharmaceutically acceptable salt of a compound according to claim 1, wherein R5 is —H, (C1-C6) -alkyl, -OR25, halogen, or —CF3. ! 3. A compound or pharmaceutically acceptable salt of a compound according to claim 1 or 2, wherein R9 is —H, (C1-C6) -alkyl, —OR25, halogen, —CF3, —NO2, or —CN. ! 4. The compound or pharmaceutically acceptable salt of the compound according to claims 1 and 2, wherein R10 is —H, (C1-C6) -alkyl, —OR25, halogen or —CF3, —NO2, or —CN. ! 5. A compound or pharmaceutically acceptable salt of a compound according to claims 1 and 2, wherein R12 is —H, (C1-C6) -alkyl, —OR25, halogen or —CF3, —NO2, or —CN. ! 6. The compound or pharmaceutically acceptable salt of the compound according to claim 1, wherein R5 is —H, (C1-C6) -alkyl, -OR25, halogen, or —CF3; and R9 is —H, (C1-C6) -alkyl, -OR25, halogen, —CF3, —NO2, or —CN. ! 7. The compound or pharmaceutically acceptable salt of the compound according to claim 1, wherein R9 is —H, (C1-C6) alkyl, —OR25, halogen, —CF3, —NO2, or —CN; ! one of R1, R2, R3, R4, R5 and R6 is —H, (C1-C6) -alkyl, —OR25, halogen, or —CF3; each of Ra and Rb represents n |
| priorityDate | 2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 192.